The U.S. Food and Drug Administration granted full approval to Moderna’s COVID-19 vaccine, Spikevax, for children aged 6 months to 11 years at high risk, despite Health Secretary Robert F. Kennedy Jr.’s May 2025 directive against routine COVID vaccinations for healthy children, according to Reuters.
This decision contradicts Kennedy’s promise to prioritize American citizens’ safety. Previously under emergency use, Spikevax targets the JN.1 variant, with Moderna planning updates for the 2025-26 season.
Kennedy, known for his skepticism towards vaccines, replaced all 17 members of the CDC’s Advisory Committee on Immunization Practices with just seven, some of whom are anti-vaccine advocates. Nevertheless, the CDC still recommends updated COVID vaccines for everyone aged six months and older, revealing a policy disagreement, according to Reuters.
Alarming Adverse Events Ignored
The FDA’s full approval of Moderna’s Spikevax, as covered by Reuters, overlooks significant safety concerns indicated by earlier data. The vaccine, which had been authorized for emergency use, presents risks that conflict with Kennedy’s safety guidelines.
“Health secretary Robert F. Kennedy Jr. had in May said the U.S. has stopped recommending routine COVID-19 vaccinations for healthy children,” Reuters noted, pointing out the inconsistency.
The U.S. Food and Drug Administration has granted full approval for Moderna’s COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday — Reuters
This approval, prioritizing Moderna’s interests, ignores the lack of placebo-controlled trials, as noted in ClinicalTrials.gov, obscuring true risks for America’s youngest citizens.
Dr. John Campbell’s Scathing Critique
Dr. John Campbell, a retired nurse educator with over 3 million YouTube subscribers, sharply criticized the FDA’s approval in a July 2025 video, calling it “bemusing.”
He emphasized the 2.7% serious adverse event rate and myocarditis risks, arguing these far outweigh benefits for low-risk children.
Moreover, Campbell highlighted that the vaccine’s lipid nanoparticles spread widely, potentially increasing harm. He also faulted the 8.8-month follow-up as too brief to evaluate long-term risks like cancer.
Furthermore, he expressed shock at the FDA’s dismissal of VAERS data, which shows a 118-fold higher adverse event rate compared to flu vaccines.
Finally, Campbell noted the vaccine’s reduced effectiveness in immunocompromised individuals, further weakening its case, per the FDA.
Public Condemns FDA’s Betrayal
Public reaction on X reflects widespread distrust, with many aligned with the Make America Healthy Again (MAHA) movement condemning the FDA’s decision.
Users captured this sentiment, stating, “FDA’s Moderna approval ignores RFK’s pledge, risking kids with myocarditis and 2.7% serious adverse events.”
This view, shared by MAHA supporters, highlights the perceived violation of Kennedy’s commitment to prioritize children’s safety over corporate interests.
BREAKING: FDA JUST APPROVED MODERNA’S COVID mRNA SHOT FOR BABIES AS YOUNG AS 6 MONTHS
The U.S. government just gave FULL APPROVAL for Moderna’s mRNA COVID injection for children aged 6 months to 11 years.
No new trials. No long-term data.
Just greenlit for the youngest, most… pic.twitter.com/O0G1xeqN5a
— HustleBitch (@HustleBitch_) July 10, 2025
A Blow to Trust in Institutions
The FDA’s decision, ignoring Kennedy’s pledge to halt unsafe vaccine policies, fuels distrust.
This undermines individual liberty and limited government, leaving parents questioning their children’s safety.
